Keywords: observational studies, real-world evidence, effectiveness, cardiovascular prevention, head-to-head comparisons, innovative Introduction Glucagon-like-peptide-1 receptors agonists (GLP-1RAs) are relatively novel drugs for the treatment of type 2 diabetes (T2D) that stimulate the incretin hormone GLP-1
[DOI] [PubMed] [Google Scholar] 221.Ahuja M., Kaidery N.A., Dutta D., Attucks O.C., Kazakov E.H., Gazaryan I., Matsumoto M., Igarashi K., Sharma S.M., Thomas B
Intracellular iron overload not only inhibits osteoblast function but also enhances osteoclast activity, thereby contributing to osteoporosis
IV use at appropriate infusion rates has not shown the same risk profile, but medical history review is standard Individuals with a known sensitivity to sulfur-containing compounds should inform their provider High-dose IV glutathione for cosmetic skin lightening, particularly in unregulated settings, has been associated with adverse events including anaphylaxis and reports of hepatotoxicity